Annual Lung SPORE Workshop (Abstract Submission)

Submitted by nusratyj on Thu, 01/05/2023 - 10:43

Abstract Submission

Submission information
Submission Number: 41
Submission ID: 110506
Submission UUID: 6b907d01-dc8e-4956-b7d5-e3c4b0ee0094

Created: Mon, 03/11/2024 - 09:03
Completed: Mon, 03/11/2024 - 09:28
Changed: Fri, 05/10/2024 - 20:49

Remote IP address: 10.208.24.212
Submitted by: Anonymous
Language: English

Is draft: No

Use the form below to submit a single abstract.  Abstracts are used to inform the agenda based the session topics.  Although abstract submission is not required to attend the meeting, in-person meeting attendance is required if the abstract is selected by the scientific committee for either oral or poster presentation.  Abstract submitters will choose a session topic, however, there is a possibility that the topic selected will be changed by the scientific committee for agenda balance. 

Abstracts may be ideas/concepts in development, work already in progress but not completed, or completed work including already published work. We are also looking for presentations outside of official SPORE project topics – anything interesting that has to do with Lung Cancer is eligible to be submitted as an abstract.

The session topics are:    

Session 1: Oncogene-driven lung cancers and resistance to targeted therapies
Session 2: Health Disparities in Lung Cancer
Session 3: Immuno-oncology
Session 4: Small Cell Lung Cancer
Session 5: Early Detection and Screening
Session 6: Cancer Biology

 

Abstract Submission Deadline: Monday, March 11, 2024 by 3pm ET.  Confirmation emails will be sent upon submission.

Abstract submission questions can be addressed to Tamara Walton. 

 

Please register before submitting an abstract

 

OMB No.: 0925-0740
Expiration Date: 9/30/2025

Public reporting burden for this collection of information is estimated to average 5 minutes per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing the collection of information. An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to: NIH, Project Clearance Branch, 6705 Rockledge Drive, MSC 7974, Bethesda, MD 20892-7974, ATTN: PRA (0925-0740). Do not return the completed form to this address.

 

Abstract Submission

Abstract Submitter's Name

First Author
Affiliation; abbreviations are welcome
Additional Authors
First Name Last Name Affiliation
Affiliation; abbreviations are welcome
Affiliation; abbreviations are welcome
Affiliation; abbreviations are welcome
Affiliation; abbreviations are welcome
Affiliation; abbreviations are welcome
Affiliation; abbreviations are welcome
Affiliation; abbreviations are welcome
Affiliation; abbreviations are welcome
Affiliation; abbreviations are welcome
Affiliation; abbreviations are welcome
Affiliation; abbreviations are welcome
Affiliation; abbreviations are welcome
Affiliation; abbreviations are welcome
Affiliation; abbreviations are welcome
Affiliation; abbreviations are welcome
Affiliation; abbreviations are welcome
Affiliation; abbreviations are welcome
more items
Select a Session Topic

Abstract Submission Instructions:

  • Abstract size is limited to 350 word maximum, 100 mg file size.  Images and hyperlinks are allowed.
  • All abstracts will be collated into a publicly published abstract book that will be distributed via email initially but will eventually be hosted on the TRP website (trp.cancer.gov).
  • Please submit the abstract MS Word (avoid .pdf).  The file should follow this nomenclature: Submitter’s last name_Institution_Session #.
  • Abstract submission questions can be addressed to Tamara Walton at tamara.walton@nih.gov.
Upload requirements
Abstract Review Status
Poster Uploaded
Poster Submission

Congratulations you have been selected by the Scientific Committee to present your abstract titled Epigenetic priming promotes acquisition of tyrosine kinase inhibitor resistance and oncogene amplification in human lung cancer in a poster session both in-person and online. 

Poster Session Requirements:

The Lung SPORE Workshop will include posters both in-person and virtual.  For poster submitters, please follow these details:

In preparation for the in-person poster session, please note the following:

  1. The poster boards are the 4’x3’ (36” x 48”), so please take that into account when printing your posters. Thumbtacks or velcro tape will be provided – all that’s needed is the actual poster.
     
  2. Poster session times are:
    1. Poster Session 1: Oncogene-driven lung cancer, resistance: Wednesday June 12 – 1:00pm- 3:00pm
    2. Poster Session 2-6: Thursday June 13 – 12:30pm-2:00pm
  3. There will be staff available to help.
     
  4. If you would prefer to FedEx your poster in advance of the meeting, please have delivered no later than June 10thto:
    Anna Arnal Estape
    798 Howard Av FMP
    112 New Haven, CT, 06519

To Submit Your Virtual Poster:

The Virtual Poster Submission Deadline is Friday, May 31, 2024 by 3pm ET. Confirmation emails will be sent upon submission.

Specifications for Online Poster Presentations:

  1. Format: Posters must be submitted in JPEG/JPG or PowerPoint .pdf file format
  2. File Size: File sizes must be no larger than 70 MB
  3. Orientation: Posters must be in landscape orientation
  4. Content: Posters should contain the following headings:
    1. Title matches title of abstract previously submitted
    2. Purpose
    3. Methods
    4. Results
    5. Conclusions

Poster submission questions can be addressed to Tamara Walton.

Must be a .jpg  or .jpeg no larger than 70 MB.
Upload requirements